Skip to main content
. 2023 Feb 14;16:457–468. doi: 10.2147/DMSO.S401397

Table 3.

Difference of Sex-Related Hormones Across Tertiles of BMD T-Score in L2-4, FN, and TH in Men and Postmenopausal Women T2DM Patients

Men (n = 149) Postmenopausal Women (n = 102)
Tertile 1 Tertile 2 Tertile 3 P value Tertile 1 Tertile 2 Tertile 3 P value
Lumbar 2–4 (L2-4)
T-score of BMD ≤0.937 0.945–1.039 ≥1.044 ≤0.812 0.813–0.938 ≥0.947
Estradiol (E2, pmol/L) 81.9±35.7 99.8±37.1 121.6±29.4 <0.001* 18.4 (18.4–22.3) 25.4 (18.4–40.5) 18.4 (18.4–31.3) 0.472
Luteinizing hormone (LH, mIU/mL) 6.8 (5.3–8.7) 7.6 (6.4–10.1) 8.5 (6.9–12.5) 0.424 30.4±15.1 29.3±13.1 33.6±16.3 0.689
FSH (mIU/mL) 8.2 (6.4–12.5) 8.3 (5.8–11.5) 9.4 (6.6–13.8) 0.428 57.1 (44.5–70.9) 50.9 (38.6–60.3) 52.3 (43.7–66.9) 0.918
Progesterone (nmol/L) 0.4 (0.2–0.6) 0.3 (0.2–0.5) 0.4 (0.2–0.6) 0.106 0.4 (0.2–0.6) 0.3 (0.2–0.6) 0.3 (0.2–0.5) 0.356
Total testosterone (nmol/L) 13.74±5.84 14.25±5.46 16.15±4.64 0.023* 0.4 (0.2–0.6) 0.4 (0.1–0.7) 0.4 (0.3–0.7) 0.487
Prolactin (PRL, mIU/L) 264.9 (211.6–382.8) 268.6 (177.8–462.6) 289.6 (206.3–402.8) 0.059 328.8 (251.8–444.9) 329.8 (248.7–411.6) 313.6 (242.9–361.1) 0.469
Femoral neck
T-score of BMD ≤0.722 0.728–0.824 ≥0.826 ≤0.618 0.622–0.709 ≥0.712
Estradiol (E2, pmol/L) 90.7±37.7 96.6±37.7 116.070±32.874 0.002* 18.4 (18.4–32.8) 18.4 (18.4–23.9) 22.8 (18.4–40.5) 0.873
Luteinizing hormone (LH, mIU/mL) 7.6 (6.3–9.0) 7.7 (6.1–10.4) 7.8 (6.4–11.1) 0.709 29.1±14.1 32.1±17.1 30.9±13.6 0.720
FSH (mIU/mL) 9.1 (6.9–13.2) 8.6 (6.3–11.3) 7.7 (4.6–12.3) 0.420 59.8 (47.9–76.3) 57.1 (39.5–69.9) 47.6 (39.1–55.9) 0.509
Progesterone (nmol/L) 0.4 (0.2–0.6) 0.4 (0.2–0.5) 0.4 (0.3–0.6) 0.247 0.3 (0.2–0.4) 0.3 (0.2–0.5) 0.3 (0.2–0.6) 0.811
Total testosterone (nmol/L) 15.4±6.1 13.5±4.8 15.4±5.2 0.121 0.3 (0.1–0.7) 0.4 (0.1–0.7) 0.5 (0.3–0.8) 0.691
Prolactin (PRL, mIU/L) 278.0 (223.3–432.2) 263.9 (175.7–418.0) 288.4 (239.5–382.8) 0.417 302.7 (208.7–375.1) 350.8 (290.2–414.3) 328.3 (251.0–406.0) 0.515
Total Hip
T-score of BMD ≤0.864 0.865–0.984 ≥0.985 ≤0.736 0.739–0.855 ≥0.857
Estradiol (E2, pmol/L) 89.3±39.4 95.5±32.0 118.27±34.7 <0.001* 18.4 (18.4–32.8) 18.4 (18.4–20.8) 24.7 (18.4–40.5) 0.964
Luteinizing hormone (LH, mIU/mL) 7.7 (6.2–10.5) 7.0 (5.5–9.5) 8.2 (6.8–9.8) 0.157 30.6±15.6 30.7±15.5 30.9±13.9 1.000
FSH (mIU/mL) 8.8 (6.7–13.1) 8.3 (6.2–11.3) 8.2 (4.8–11.9) 0.436 58.8 (44.8–75.3) 59.3 (43.5–69.3) 47.6 (39.1–55.9) 0.355
Progesterone (nmol/L) 0.4 (0.2–0.6) 0.4 (0.2–0.6) 0.4 (0.192–0.5) 0.994 0.3 (0.2–0.5) 0.3 (0.2–0.5) 0.2 (0.2–0.4) 0.981
Total testosterone (nmol/L) 14.8±5.6 14.3±5.4 15.1±5.3 0.791 0.4 (0.1–0.7) 0.4 (0.2–0.7) 0.5 (0.3–0.8) 0.678
Prolactin (PRL, mIU/L) 289.4 (220.8–427.5) 286.5 (208.0–463.2) 265.9 (205.4–349.1) 0.696 329.8 (236.1–381.8) 328.3 (248.7–411.6) 328.8 (271.9–406.6) 0.123
Minimum T-score of any site
T-score of BMD ≤-1.9 −1.8 ~ −1.1 ≥-1.0 ≤-2.5 −2.4 ~ −1.7 ≥-1.6
Estradiol (E2, pmol/L) 85.0±37.2 100.9±36.8 117.8±32.3 <0.001* 18.4 (18.4–30.6) 18.4 (18.4–30.5) 22.3 (18.4–33.5) 0.142
Luteinizing hormone (LH, mIU/mL) 14.5±5.9 14.4±5.1 15.4±5.2 0.603 0.3 (0.1–0.6) 0.4 (0.2–0.7) 0.6 (0.3–0.8) 0.111
FSH (mIU/mL) 0.4 (0.2–0.6) 0.3 (0.2–0.5) 0.4 (0.2–0.6) 0.348 0.2 (0.2–0.4) 0.4 (0.2–0.6) 0.3 (0.2–0.6) 0.112
Progesterone (nmol/L) 7.0 (5.6–8.9) 7.7 (6.5–9.8) 8.5 (6.7–12.9) 0.079 32.8±13.4 30.7±14.9 29.5±16.4 0.655
Total testosterone (nmol/L) 8.2 (6.4–12.6) 8.9 (6.3–11.6) 8.3 (4.8–12.9) 0.421 60.8 (50.0–73.9) 53.8 (41.8–70.9) 46.0 (38.9–56.7) 0.365
Prolactin (PRL, mIU/L) 253.3 (195.9–343.7) 288.7 (211.9–450.1) 287.4 (214.4–398.9) 0.176 312.5 (236.1–363.2) 349.9 (263.5–453.7) 311.5 (249.3–393.7) 0.349

Note: * p<0.05.